Research Projects & Grants

For Profit Organization

• A phase 2/3, randomized, double-masked, sham-controlled trial of QPI-1007 delivered by single or multi-dose intravitreal injection(s) to subjects with acute nonarteritic anterior ischemic optic neuropathy (NAION), Role: Investigator, Quark Pharmaceuticals, (01/2019 - 01/2020) Status: Completed

Internal

• Pediatric Idiopathic lntracranial Hypertension, Role: Investigator, LLU Dept. of Neurosurgery, (07/2024) Status: Approved
• Visual Outcomes in Patients Treated with Acetazolamide for Papilledema Secondary to Intracranial Mass Effect, Role: Investigator, LLU Dept. of Ophthalmology, (01/2024) Status: Approved
• A Retrospective Chart Review Assessing the Outcomes of Venous Stenting in IIH Patients, Role: PI, LLU Dept. of Ophthalmology, (06/2023 - 06/2025) Status: Approved
• The Practicality of metabolic PET CT in unexplained vision loss: A Case Series, Role: PI, LLU Dept. of Ophthalmology, (06/2022) Status: Approved
• Retrospective analysis of patients with ventriculoperitoneal (VP) shunt presenting to the emergency department at a large tertiary care medical center in Southern California, Role: PI, LLU Dept. of Ophthalmology, (10/2020) Status: Approved
• Comparison of Optical Coherence Tomography Measurement of Ganglion Cell Layer between Patients with Severe Glaucoma and Those with Other Etiologies of Optic Atrophy, Role: PI, LLU Dept. of Ophthalmology, (06/2020) Status: Approved
• Decreased stereo acuity in post-concussion syndrome, Role: PI, LLU Dept. of Ophthalmology, (12/2019) Status: Approved
• Ocular Signs and symptoms on post-concussions syndrome, Role: PI, LLU Dept. of Ophthalmology, (12/2019) Status: Approved